Psychedelic therapy for body dysmorphic disorder

Psychedelic-assisted psychotherapy should be investigated as a treatment for body dysmorphic disorder (BDD). BDD involves appearance-based preoccupations and compulsions. Although existing treatments are safe and effective, non-response and relapse rates remain high. Preliminary evidence indicates safety, feasibility, and potential efficacy of psychedelic treatments for disorders sharing psychopathological mechanisms with BDD. Based on this evidence, qualitative reports, and theoretical proposals, the authors argue for a phase 2a study to assess safety and feasibility of psychedelic-assisted psychotherapy in BDD, and offer suggestions for future research.

Study at a glance

Abstract

Abstract In this opinion piece we propose the investigation of psychedelic-assisted psychotherapy for the treatment of body dysmorphic disorder (BDD). BDD is a psychiatric disorder characterised by appearance-based preoccupations and accompanying compulsions. While safe and effective treatments for BDD exist, non-response and relapse rates remain high. Therefore, there is a need to investigate promising new treatment options for this highly debilitating condition. Preliminary evidence suggests safety, feasibility, and potential efficacy of psychedelic treatments in disorders that share similar psychopathological mechanisms with BDD. Drawing on this evidence, as well as on relevant qualitative reports and theoretical proposals, we argue that it would be worthwhile to conduct a phase 2a study aimed at assessing the safety and feasibility of psychedelic-assisted psychotherapy in BDD. We also offer some suggestions for how future research ought to proceed.